Charles River Laboratories International (CRL) Net Income towards Common Stockholders (2016 - 2025)
Charles River Laboratories International (CRL) has 16 years of Net Income towards Common Stockholders data on record, last reported at -$276.6 million in Q4 2025.
- For Q4 2025, Net Income towards Common Stockholders fell 28.21% year-over-year to -$276.6 million; the TTM value through Dec 2025 reached -$144.3 million, down 1501.75%, while the annual FY2025 figure was -$144.3 million, 1501.75% down from the prior year.
- Net Income towards Common Stockholders reached -$276.6 million in Q4 2025 per CRL's latest filing, down from $54.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $189.1 million in Q4 2022 and bottomed at -$276.6 million in Q4 2025.
- Average Net Income towards Common Stockholders over 5 years is $61.6 million, with a median of $90.0 million recorded in 2021.
- Peak YoY movement for Net Income towards Common Stockholders: surged 48.94% in 2022, then crashed 215.3% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then fell by 1.07% to $187.1 million in 2023, then plummeted by 215.3% to -$215.7 million in 2024, then fell by 28.21% to -$276.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$276.6 million in Q4 2025, $54.4 million in Q3 2025, and $52.3 million in Q2 2025.